Updates on Ozempic & GLP-1 Lawsuit FAQs

  • Ozempic lawsuit 2026 guide covering MDL 3094, gastroparesis claims, FDA gastrointestinal warnings, eligibility and settlement factors

    Is there an Ozempic class action lawsuit?

    Published On: November 13, 2026Categories: By

    Short answer: Not for injuries. The Ozempic and GLP-1 injury cases are individual lawsuits grouped for pretrial work in two federal MDLs, 3094 (stomach injuries, 4,082 pending) and 3163 (vision loss, 278 pending), not a single class action.In a class action one plaintiff represents everyone and members share one result. In an MDL each person [...]

  • Ozempic lawsuit 2026 guide covering MDL 3094, gastroparesis claims, FDA gastrointestinal warnings, eligibility and settlement factors

    Which drugs are in the GLP-1 lawsuit: Wegovy, Mounjaro, Zepbound?

    Published On: November 13, 2026Categories: By

    Short answer: Eight drugs are at issue in the federal stomach-injury MDL: Ozempic, Wegovy, Rybelsus, Victoza and Saxenda made by Novo Nordisk, and Trulicity, Mounjaro and Zepbound made by Eli Lilly. The court’s August 15, 2025 opinion lists all eight.All are GLP-1 receptor agonists (Mounjaro and Zepbound also act on a second hormone, GIP). They [...]

  • Ozempic lawsuit 2026 guide covering MDL 3094, gastroparesis claims, FDA gastrointestinal warnings, eligibility and settlement factors

    Is there an Ozempic settlement, and how much is it worth?

    Published On: November 13, 2026Categories: By

    Short answer: No. As of November 13, 2026, Novo Nordisk and Eli Lilly have not announced any settlement of the GLP-1 injury lawsuits, no jury has returned a verdict, and no bellwether trial is scheduled. Any “average Ozempic settlement” figure online is a forecast, not money that has been paid.Settlement talks in mass torts usually [...]

  • Ozempic lawsuit 2026 guide covering MDL 3094, gastroparesis claims, FDA gastrointestinal warnings, eligibility and settlement factors

    Who qualifies for an Ozempic gastroparesis lawsuit?

    Published On: November 13, 2026Categories: By

    Short answer: Generally, someone who took a GLP-1 drug such as Ozempic, Wegovy or Mounjaro and was then diagnosed with a serious stomach or bowel injury. For gastroparesis specifically, the MDL court ruled on August 15, 2025 that the diagnosis must be supported by a gastric emptying study, an objective test, not symptoms alone.Plaintiffs’ leadership [...]

  • Ozempic lawsuit 2026 guide covering MDL 3094, gastroparesis claims, FDA gastrointestinal warnings, eligibility and settlement factors

    Is there an Ozempic vision loss (NAION) lawsuit?

    Published On: November 13, 2026Categories: By

    Short answer: Yes. On December 15, 2025 the Judicial Panel on Multidistrict Litigation created MDL 3163 for lawsuits claiming GLP-1 drugs caused NAION (non-arteritic anterior ischemic optic neuropathy), a sudden loss of blood flow to the optic nerve that can cause permanent vision loss. 278 cases were pending on November 2, 2026.The panel kept vision [...]

  • Ozempic lawsuit 2026 guide covering MDL 3094, gastroparesis claims, FDA gastrointestinal warnings, eligibility and settlement factors

    What is the latest Ozempic lawsuit update?

    Published On: November 13, 2026Categories: By

    Short answer: As of the JPML report dated November 2, 2026, 4,082 lawsuits are pending in MDL 3094 (stomach and bowel injuries) and 278 in MDL 3163 (NAION vision loss). Both are before Judge Karen S. Marston in the Eastern District of Pennsylvania. No settlement has been announced and no bellwether trial date is set.The [...]

Filter Posts

Browse by Category